Cardio Diagnostics Stock Forecast - Double Exponential Smoothing
| CDIO Stock | USD 1.78 0.06 3.26% |
Cardio Stock outlook is based on your current time horizon. Although Cardio Diagnostics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cardio Diagnostics' systematic risk associated with finding meaningful patterns of Cardio Diagnostics fundamentals over time.
As of today, the RSI of Cardio Diagnostics' share price is approaching 34 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Cardio Diagnostics, making its price go up or down. Momentum 34
Sell Stretched
Oversold | Overbought |
Wall Street Target Price 60.0001 | EPS Estimate Current Quarter (1.80) | Quarterly Revenue Growth (0.57) |
Using Cardio Diagnostics hype-based prediction, you can estimate the value of Cardio Diagnostics Holdings from the perspective of Cardio Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The Double Exponential Smoothing forecasted value of Cardio Diagnostics Holdings on the next trading day is expected to be 1.74 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.76. Cardio Diagnostics after-hype prediction price | USD 1.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cardio Diagnostics to cross-verify your projections. Cardio Diagnostics Additional Predictive Modules
Most predictive techniques to examine Cardio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cardio using various technical indicators. When you analyze Cardio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cardio Diagnostics Double Exponential Smoothing Price Forecast For the 30th of January
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Cardio Diagnostics Holdings on the next trading day is expected to be 1.74 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.05, and the sum of the absolute errors of 9.76.Please note that although there have been many attempts to predict Cardio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cardio Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cardio Diagnostics Stock Forecast Pattern
| Backtest Cardio Diagnostics | Cardio Diagnostics Price Prediction | Buy or Sell Advice |
Cardio Diagnostics Forecasted Value
In the context of forecasting Cardio Diagnostics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cardio Diagnostics' downside and upside margins for the forecasting period are 0.02 and 9.04, respectively. We have considered Cardio Diagnostics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Cardio Diagnostics stock data series using in forecasting. Note that when a statistical model is used to represent Cardio Diagnostics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0275 |
| MAD | Mean absolute deviation | 0.1627 |
| MAPE | Mean absolute percentage error | 0.0553 |
| SAE | Sum of the absolute errors | 9.7622 |
Predictive Modules for Cardio Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardio Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cardio Diagnostics After-Hype Price Density Analysis
As far as predicting the price of Cardio Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cardio Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cardio Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cardio Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Cardio Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cardio Diagnostics' historical news coverage. Cardio Diagnostics' after-hype downside and upside margins for the prediction period are 0.08 and 8.81, respectively. We have considered Cardio Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cardio Diagnostics is slightly risky at this time. Analysis and calculation of next after-hype price of Cardio Diagnostics is based on 3 months time horizon.
Cardio Diagnostics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cardio Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cardio Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cardio Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.10 | 7.31 | 2.97 | 0.04 | 21 Events / Month | 4 Events / Month | In about 21 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.78 | 1.50 | 15.71 |
|
Cardio Diagnostics Hype Timeline
Cardio Diagnostics is currently traded for 1.78. The entity has historical hype elasticity of -2.97, and average elasticity to hype of competition of 0.04. Cardio is forecasted to decline in value after the next headline, with the price expected to drop to 1.5. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -15.71%, whereas the daily expected return is currently at -1.1%. The volatility of related hype on Cardio Diagnostics is about 19236.84%, with the expected price after the next announcement by competition of 1.82. The company has price-to-book (P/B) ratio of 0.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cardio Diagnostics recorded a loss per share of 11.91. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 13th of May 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 21 days. Check out Historical Fundamental Analysis of Cardio Diagnostics to cross-verify your projections.Cardio Diagnostics Related Hype Analysis
Having access to credible news sources related to Cardio Diagnostics' direct competition is more important than ever and may enhance your ability to predict Cardio Diagnostics' future price movements. Getting to know how Cardio Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cardio Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ADXN | Addex Therapeutics | 0.44 | 7 per month | 0.00 | (0.02) | 7.92 | (7.12) | 26.68 | |
| BCLI | Brainstorm Cell Therapeutics | (0.01) | 8 per month | 0.00 | (0.05) | 9.09 | (6.67) | 24.01 | |
| NRSN | Neurosense Therapeutics | 0.01 | 9 per month | 0.00 | (0.04) | 12.82 | (7.48) | 34.62 | |
| MTNB | Matinas BioPharma Holdings | 0.02 | 6 per month | 0.00 | (0.12) | 11.67 | (10.67) | 39.32 | |
| CELZ | Creative Medical Technology | (0.32) | 5 per month | 0.00 | (0.11) | 9.31 | (11.22) | 50.90 | |
| ADIL | Adial Pharmaceuticals | (0.01) | 8 per month | 0.00 | (0.19) | 5.56 | (6.25) | 16.67 | |
| RADX | Radiopharm Theranostics Limited | 0.00 | 0 per month | 7.72 | 0.05 | 7.44 | (7.58) | 193.18 | |
| TCRT | Alaunos Therapeutics | 0.16 | 9 per month | 5.61 | 0.02 | 9.61 | (10.55) | 24.31 | |
| BCDA | Biocardia | 0.07 | 8 per month | 0.00 | (0.04) | 5.93 | (5.76) | 21.46 | |
| IBO | Impact BioMedical | 0.02 | 9 per month | 0.00 | (0.03) | 8.00 | (7.41) | 61.57 |
Other Forecasting Options for Cardio Diagnostics
For every potential investor in Cardio, whether a beginner or expert, Cardio Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cardio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cardio. Basic forecasting techniques help filter out the noise by identifying Cardio Diagnostics' price trends.Cardio Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardio Diagnostics stock to make a market-neutral strategy. Peer analysis of Cardio Diagnostics could also be used in its relative valuation, which is a method of valuing Cardio Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cardio Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Cardio Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardio Diagnostics shares will generate the highest return on investment. By undertsting and applying Cardio Diagnostics stock market strength indicators, traders can identify Cardio Diagnostics Holdings entry and exit signals to maximize returns.
Cardio Diagnostics Risk Indicators
The analysis of Cardio Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cardio Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cardio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.09 | |||
| Standard Deviation | 7.1 | |||
| Variance | 50.46 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cardio Diagnostics
The number of cover stories for Cardio Diagnostics depends on current market conditions and Cardio Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cardio Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cardio Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cardio Diagnostics Short Properties
Cardio Diagnostics' future price predictability will typically decrease when Cardio Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cardio Diagnostics Holdings often depends not only on the future outlook of the potential Cardio Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardio Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.9 M | |
| Cash And Short Term Investments | 7.8 M |
Check out Historical Fundamental Analysis of Cardio Diagnostics to cross-verify your projections. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Will Biotechnology sector continue expanding? Could Cardio diversify its offerings? Factors like these will boost the valuation of Cardio Diagnostics. Projected growth potential of Cardio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cardio Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.91) | Revenue Per Share | Quarterly Revenue Growth (0.57) | Return On Assets | Return On Equity |
Cardio Diagnostics's market price often diverges from its book value, the accounting figure shown on Cardio's balance sheet. Smart investors calculate Cardio Diagnostics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Cardio Diagnostics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cardio Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardio Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.